Aspirin for Preventing the Recurrence of Venous Thromboembolism
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending anticoagulation prevents recurrences but is associated with increased bleeding. The benefit of aspirin for the prevention of recurrent venous thromboembolism is unknown. METHODS: In this multicenter, investigator-initiated, double-blind study, patients with first-ever unprovoked venous thromboembolism who had completed 6 to 18 months of oral anticoagulant treatment were randomly assigned to aspirin, 100 mg daily, or placebo for 2 years, with the option of extending the study treatment. The primary efficacy outcome was recurrence of venous thromboembolism, and major bleeding was the primary safety outcome. RESULTS: Venous thromboembolism recurred in 28 of the 205 patients who received aspirin and in 43 of the 197 patients who received placebo (6.6% vs. 11.2% per year; hazard ratio, 0.58; 95% confidence interval [CI], 0.36 to 0.93) (median study period, 24.6 months). During a median treatment period of 23.9 months, 23 patients taking aspirin and 39 taking placebo had a recurrence (5.9% vs. 11.0% per year; hazard ratio, 0.55; 95% CI, 0.33 to 0.92). One patient in each treatment group had a major bleeding episode. Adverse events were similar in the two groups. CONCLUSIONS: Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding. (Funded by the University of Perugia and others; WARFASA ClinicalTrials.gov number, NCT00222677.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [309]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., & Weg, J. G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.176s · Cited by 2,042
Self-citationAntithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Self-citation(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
del Conde, I., Shrimpton, C. N., Thiagarajan, P., & López, J. A. (2005) · Blood · doi:10.1182/blood-2004-03-1095 · Cited by 1,029
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Research works printed but not linked: 2
- Schulman S, 2011, J Thromb Haemost, 9, 731
- Schulman S, 2011, J Thromb Haemost, 9, 22
Cited by
Items 201–300 of 630
Dobesh, P. P., & Fanikos, J. R. (2014) · Drugs · doi:10.1007/s40265-014-0301-x · Cited by 24
Aspirin in the primary prophylaxis of venous thromboembolism in surgical patients
Sahebally, S. M., Healy, D. A., & Walsh, S. R. (2015) · The Surgeon · doi:10.1016/j.surge.2015.05.001 · Cited by 23
Ashrani, A. A., Barsoum, M. K., Crusan, D. J., Petterson, T. M., Bailey, K. R., & Heit, J. A. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.04.005 · Cited by 24
Barbar, S., Milan, M., Campello, E., Spiezia, L., Piovella, C., Pesavento, R., & Prandoni, P. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-04-0396 · Cited by 26
Self-citationTomkowski, W. Z., Kuca, P., Urbanek, T., Chmielewski, D., Krasiński, Z., Pruszczyk, P., Windyga, J., Oszkinis, G., Jawień, A., Burakowski, J., et al. (2017) · Acta Angiologica · doi:10.5603/aa.2017.0008 · Cited by 27
Factor XII Deficiency Mimicking Bleeding Diathesis: A Unique Presentation and Diagnostic Pitfall
Fernandes, H., Newton, S. L., & Rodrigues, J. M. (2018) · Cureus · doi:10.7759/cureus.2817 · Cited by 23
Update on extended treatment for venous thromboembolism
Peñaloza-Martínez, E., Rodríguez, P. D., Proietti, M., Fernández‐Llamazares, G. S., Mendo, C. L., Álvarez-Sala, J. L., Marra, A. M., & del Toro‐Cervera, J. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1538564 · Cited by 26
Seagrave, K. G., Fletcher, J., & Hitos, K. (2020) · International Angiology · doi:10.23736/s0392-9590.19.04086-0 · Cited by 22
Cvirn, G., Kneihsl, M., Rossmann, C. R., Paar, M., Gattringer, T., Schlagenhauf, A., Leschnik, B., Köestenberger, M., Tafeit, E., Reibnegger, G. J., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00012 · Cited by 22
Aspirin Is Associated With Reduced Rates of Venous Thromboembolism in Older Patients With Cancer
Li, P., Ning, Y., Li, M., Cai, P., Siddiqui, A. D., Liu, E. Y., Hadley, M. L., Wu, F., Pan, S. F., Dixon, R. A. F., et al. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420925021 · Cited by 23
Diagnosis and treatment of acute pulmonary embolism
Widimsky, J., Jr. (2013) · Cor et Vasa · doi:10.1016/j.crvasa.2013.10.001 · Cited by 22
Heller, S., Secrist, E. S., Shahi, A., Chen, A. F., & Parvizi, J. (2016) · The Journal of Arthroplasty · doi:10.1016/j.arth.2015.12.042 · Cited by 24
Yang, W., Deng, C., Liu, P., Hu, Y., Luo, Z. Y., & Cai, K. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.055 · Cited by 22
Chavan, S., & Ho, K. M. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-09-0658 · Cited by 22
Optimal treatment duration of venous thrombosis
Ageno, W., Dentali, F., Donadini, M. P., & Squizzato, A. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12234 · Cited by 21
Self-citationTarango, C., Schulman, S., Betensky, M., & Goldenberg, N. A. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2018.1407241 · Cited by 21
Pompilio, G., Integlia, D., Raffetto, J. D., & Palareti, G. (2020) · TH Open · doi:10.1055/s-0040-1709731 · Cited by 21
Treatment patterns of venous thromboembolism in a real-world population: The Q-VTE study cohort
Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.07.002 · Cited by 20
Figini, F., Latib, A., Maisano, F., Montorfano, M., Chieffo, A., Carlino, M., Cioni, M., Basavarajaiah, S., Ferrarello, S., Giannini, F., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.023 · Cited by 20
Tefferi, A., & Barbui, T. (2015) · American Journal of Hematology · doi:10.1002/ajh.24037 · Cited by 20
Wolff, G., Navarese, E. P., Brockmeyer, M., Lin, Y., Karathanos, A., Kołodziejczak, M. M., Kubica, J., Polzin, A., Zeus, T., Westenfeld, R., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.088 · Cited by 20
Jiang, Q., Bai, J., Jin, J., Shi, J., & Qu, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00876 · Cited by 20
Liu, S., Shen, Y., Chen, J., Ruan, Z., Li, H., Wang, K., Xi, X., & Mao, J. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101302 · Cited by 24
Antiplatelet drugs and liver fibrosis
Czajka, P., Przybyłkowski, A. M., Nowak, A., Postula, M. A., Wolska, M., Mirowska-Guzel, D. M., Członkowska, A., & Eyileten, C. (2021) · Platelets · doi:10.1080/09537104.2021.1883574 · Cited by 19
Platelet integrin αIIbβ3 plays a key role in a venous thrombogenesis mouse model
Adair, B. D., Field, C. O., Alonso, J. L., Xiong, J.-P., Deng, S., Ahn, H.-S., Mashin, E., Clish, C. B., Agthoven, J. F. V., Yeager, M. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52869-3 · Cited by 20
Diretrizes sobre trombose venosa profunda da Sociedade Brasileira de Angiologia e Cirurgia Vascular
Sobreira, M. L., Marques, M. A., Paschôa, A. F., Ribeiro, A. J. A., Casella, I. B., Burihan, M. C., Matielo, M. F., Soares, R. D. A., de Araújo, W. J. B., Joviliano, E. É., et al. (2024) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202301071 · Cited by 27
Update on management of cerebral venous thrombosis
Rosa, S., Fragata, I., & de Sousa, D. A. (2024) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001329 · Cited by 19
Prandoni, P. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.013 · Cited by 21
Self-citationSnir, O., Wilsgård, L., Latysheva, N., Wahlund, C. J. E., Brækkan, S. K., Hindberg, K., & Hansen, J. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15638 · Cited by 21
Aspirin as added prophylaxis for deep vein thrombosis in trauma: A retrospective case-control study
Brill, J. B., Calvo, R. Y., Wallace, J. D., Lewis, P. R., Bansal, V., Sise, M. J., & Shackford, S. R. (2016) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000977 · Cited by 21
Wallace, R. A., Anderson, M. A., See, K., Gorelik, A., Irving, L. B., & Manser, R. L. (2017) · Internal Medicine Journal · doi:10.1111/imj.13382 · Cited by 20
Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review
Orsi, F. A., Cannegieter, S. C., & Lijfering, W. M. (2019) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0039-1687911 · Cited by 21
Anticoagulation management strategies in heart transplantation
Rizk, J. G., & Mehra, M. R. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.02.002 · Cited by 19
Coleman, C. I., Limone, B. L., Bookhart, B. K., Mody, S. H., & Nutescu, E. A. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.006 · Cited by 18
“While each of these agents have been compared to placebo for extended VTE treatment [1,6,7,13,4,18,40–43], only dabigatran [42] has been compared to warfarin as part of a head-to-head randomized trial.”
BackgroundMethodInfluentialFatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
van der Wall, S. J., van der Pol, L. M., Ende-Verhaar, Y. M., Cannegieter, S. C., Schulman, S., Prandoni, P., Rodger, M. A., Huisman, M. V., & Klok, F. A. (2018) · European Respiratory Review · doi:10.1183/16000617.0094-2018 · Cited by 20
Self-citationWeitz, J. I., & Chan, N. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1679906 · Cited by 18
Thrombophilia Testing, Recurrent Thrombosis, and Women’s Health
Piazza, G. (2014) · Circulation · doi:10.1161/circulationaha.113.007664 · Cited by 19
Persistent global hypercoagulability in long-term survivors of acute pulmonary embolism
Chow, V., Reddel, C. J., Pennings, G. J., Chung, T., Ng, A. C. C., Curnow, J. L., & Kritharides, L. (2015) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000285 · Cited by 18
Signorelli, S. S., Conti, G. O., Fiore, M., Cangiano, F., Zuccarello, P., Gaudio, A., & Ferrante, M. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s236286 · Cited by 18
Reproductive issues in women on direct oral anticoagulants
Beyer‐Westendorf, J., & Marten, S. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12512 · Cited by 18
Uresandi, F., Monréal, M., García-Bragado, F., Domenech, P., Lecumberri, R., Escribano, P., Zamorano, J. L., Jiménez, S., Ruiz‐Artacho, P., Lozano, F., et al. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2013.10.008 · Cited by 40
Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis
Hsu, C., Brahmandam, A., Brownson, K. E., Huynh, N., Reynolds, J., Lee, A. I., Fares, W. H., & Chaar, C. I. O. (2019) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.10.020 · Cited by 20
Extended Treatment of Venous Thromboembolism
Connors, J. M. (2013) · New England Journal of Medicine · doi:10.1056/nejme1215678 · Cited by 19
Li, Y., Gu, J., Ge, J., Kong, J., & Shang, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113534 · Cited by 17
Statins and prevention of venous thromboembolism: Myth or reality?
Gaertner, S., Cordeanu, E., Nouri, S., Mirea, C., & Stéphan, D. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.11.007 · Cited by 18
Antiplatelet therapy in prevention of cardio- and venous thromboembolic events
Steinhubl, S. R., Eikelboom, J. W., Hylek, E. M., Dauerman, H. L., Smyth, S. S., & Becker, R. C. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-1023-8 · Cited by 17
Konstantinides, S., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D. A., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M. J. C., Kucher, N., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.12.002 · Cited by 25
Self-citationGaertner, S., Cordeanu, E., Mirea, C., Frantz, A., Auger, C., Bilbault, P., Ohlmann, P., Schini‐Kerth, V. B., & Stéphan, D. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.055 · Cited by 19
Rivaroxaban for the Treatment of Pulmonary Embolism
Vanassche, T., & Verhamme, P. B. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0041-4 · Cited by 18
Aspirin and the Prevention of Venous Thromboembolism
Becker, R. C. (2012) · New England Journal of Medicine · doi:10.1056/nejme1201911 · Cited by 18
Guenther, F., Herr, N., Mauler, M., Witsch, T., Roming, F., Hein, L., Boeynaems, J. M., Robaye, B., Idzko, M., Bode, C., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12206 · Cited by 16
Madridano, O., del Toro, J., Lorenzo, A., Martín, M., Cerezo, J. G., Hernández, L. M., Prandoni, P., Monréal, M., Arcelus, J. I., Arroyo, M., et al. (2015) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2014.11.002 · Cited by 18
Self-citationAspirin and recurrent venous thromboembolism
Prandoni, P., Noventa, F., & Milan, M. (2013) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355512475040 · Cited by 16
Self-citationLjungqvist, M., Holmström, M., Kieler, H., Odeberg, J., & Lärfars, G. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.11.039 · Cited by 20
Sharifi, M., Freeman, W. K., Bay, R. C., Sharifi, M., & Schwartz, F. N. (2015) · Vascular Medicine · doi:10.1177/1358863x14553882 · Cited by 17
Quintero, M., Tasić, L., Costa, T. B. B. C., Stanišić, D., Montalvão, S. A. D. L., Huber, S. C., & Annichino‐Bizzacchi, J. M. (2021) · Metabolites · doi:10.3390/metabo11120874 · Cited by 16
Pulmonary embolism: Care standards in 2018
Borohovitz, A., Weinberg, M. D., & Weinberg, I. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.12.005 · Cited by 16
Management of a decompensated acute-on-chronic intracranial venous sinus thrombosis
Candel, C. S., Hellstern, V., Beitlich, T., Pérez, M. A., Bäzner, H., & Henkes, H. H. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419895157 · Cited by 16
Mavromanoli, A. C., Barco, S., & Konstantinides, S. (2021) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12509 · Cited by 15
ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism
D’Agostino, C., Zonzin, P., Enea, I., Gulizia, M. M., Ageno, W., Agostoni, P., Azzarito, M., Becattini, C., Bongarzoni, A., Bux, F., et al. (2017) · European Heart Journal Supplements · doi:10.1093/eurheartj/sux030 · Cited by 16
Self-citationSultan, S. M., Jackson, D. S., Erhard, H. A., Greenspun, D. T., Benacquista, T., Garfein, E. S., & Weichman, K. E. (2017) · Journal of Reconstructive Microsurgery · doi:10.1055/s-0037-1608629 · Cited by 15
Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism
Lim, H. Y., Nandurkar, H. H., & Ho, P. W. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0038-1637750 · Cited by 15
Haj, A. K., Paul, D. S., Jurgens, S. J., Eswaran, H., Weng, L.-C. C., Ryu, J. H., Espada, A. R., Chaudhry, S. A., Feingold, L. M., Burke, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62789-5 · Cited by 14
Venous thromboembolism: current management
Stevens, H., Tran, H. A., & Gibbs, H. H. (2019) · Australian Prescriber · doi:10.18773/austprescr.2019.039 · Cited by 14
Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
Díaz, T., Trachtenberg, B. H., Abraham, S. J., Rao, K. S. J., & Durant-Archibold, A. A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.562708 · Cited by 16
Khan, F. A., Rahman, A. A., Tritschler, T., Carrier, M., Kearon, C., Weitz, J. I., Schulman, S., Couturaud, F., Becattini, C., Agnelli, G., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1690-8728 · Cited by 18
Self-citationMarcucci, M., Iorio, A., & Douketis, J. D. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-012-0225-2 · Cited by 15
Schmitz, A., Romann, L., Kienbaum, P., Pavlaković, G., Werdehausen, R., & Hohlfeld, T. (2016) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000581 · Cited by 14
The prevention of venous thromboembolism recurrence in the elderly: a still open issue
Palareti, G., & Poli, D. (2018) · Expert Review of Hematology · doi:10.1080/17474086.2018.1526667 · Cited by 14
Hounkpe, B. W., Benatti, R. O., Carvalho, B. S., & Paula, E. V. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235501 · Cited by 20
Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in mice
Stivala, S., Savarese, G., Camici, G. G., Lüscher, T. F., Wagner, D. D., Reiner, M. F., Martinod, K., & Beer, J. H. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0200 · Cited by 15
Wakefield, T. W., Andrea, T., & Henke, P. K. (2014) · Circulation · doi:10.1161/circulationaha.114.012235 · Cited by 16
Recent Pathophysiological Insights Are Advancing the Treatment of Venous Thromboembolism
Singh, S., Kumar, P., Yadav, S. K., Jaffer, F. A., & Reed, G. L. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.12.004 · Cited by 17
Li, A., Khatib, R., Lopes, L. C., Aloweni, F. B. A. B., Lu, L., He, Q., Wu, J., Zhang, P., Tang, Y., Pavalagantharajah, S., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015371 · Cited by 14
Cerebral Sinovenous Thrombosis in Infants and Children: A Practical Approach to Management
Mandel‐Shorer, N., Sabapathy, C. A., Krishnan, P., Sharma, M., Goldenberg, N. A., Brandão, L. R., & Moharir, M. D. (2022) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2022.100993 · Cited by 13
Pulmonary embolism: current and new treatment options
Walter, R. J., Moores, L. K., & Jiménez, D. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.936931 · Cited by 13
Update on diagnosis and anticoagulant therapy for venous thromboembolism
Stevens, H., & Tran, H. A. (2018) · Internal Medicine Journal · doi:10.1111/imj.14063 · Cited by 13
Omari, A. M., Parcells, B. W., Levine, H. B., Seidenstein, A., Parvizi, J., & Klein, G. R. (2021) · The Bone & Joint Journal · doi:10.1302/0301-620x.103b6.bjj-2020-2436.r1 · Cited by 15
Hull, C. M., & Harris, J. A. (2015) · Sports Medicine · doi:10.1007/s40279-015-0360-5 · Cited by 13
Agrawal, V., & Kim, E. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1111-2 · Cited by 15
Quon, P., Le, H. H., Raymond, V., Mtibaa, M., & Moshyk, A. (2016) · Journal of Medical Economics · doi:10.3111/13696998.2016.1141780 · Cited by 12
Advances in the management of venous thromboembolism
Schulman, S. (2012) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2012.06.003 · Cited by 13
Role of platelet count in a murine stasis model of deep vein thrombosis
Mathews, R., Setthavongsack, N., Le-Cook, A., Kaempf, A. J., Loftis, J. M., Woltjer, R. L., Lorentz, C. U., Revenko, A. S., Hinds, M. T., & Nguyen, K. P. (2023) · Platelets · doi:10.1080/09537104.2023.2290916 · Cited by 12
JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis
Tamura, Y., Kusunose, K., Yamashita, Y., Akagi, T., Atsukawa, M., Fukumoto, Y., Goda, A., Goto, S., Hatano, M., Ikeda, M., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-1144 · Cited by 14
An Update on the “Novel” and Direct Oral Anticoagulants, and Long-Term Anticoagulant Therapy
Djulbegovic, M., & Lee, A. I. (2018) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2018.04.010 · Cited by 14
Ngwenyama, T. R., Herring, J. M., O'Brien, M., Hartman, S. K., Galloway, K. A., & O’Brien, R. T. (2014) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12235 · Cited by 12
Predicting venous thrombosis in patients undergoing elective splenectomy
Szász, P., Ardestani, A., Shoji, B. T., Brooks, D. C., & Tavakkoli, A. (2019) · Surgical Endoscopy · doi:10.1007/s00464-019-07007-2 · Cited by 13
Antiplatelet agents for the treatment of deep venous thrombosis
Flumignan, C. D. Q., Flumignan, R. L., & Baptista-Silva, J. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012369 · Cited by 13
Management of idiopathic venous thromboembolism
Cosmi, B. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2016.1248406 · Cited by 12
Zou, H., Li, Y., & Xu, G. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1637-y · Cited by 12
Chemoprophylaxis and Management of Venous Thromboembolism in Microvascular Surgery
Mirzamohammadi, F., Silva, O. N. N., Leaf, R. K., Eberlin, K. R., & Valerio, I. L. (2023) · Seminars in Plastic Surgery · doi:10.1055/s-0042-1760381 · Cited by 11
Chendrasekhar, A., Pate, A. J., Baltazar, G. A., Labana, S., Kim, J., & Bhagat, T. (2015) · International Journal of General Medicine · doi:10.2147/ijgm.s72259 · Cited by 11
Şentürk, A., Uçar, E. Y., Berk, S., Özlü, T., Altınsoy, B., Dabak, G., Çakır, E., Kadıoglu, E. E., Şen, H. S., Özsu, S., et al. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029614564863 · Cited by 10
Andrade, A. A., Li, J., Radford, M. J., Nilasena, D. S., & Gage, B. F. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3201-1 · Cited by 12
Management of Venous Thromboembolism
Burnett, B. (2012) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2012.11.004 · Cited by 10
Imberti, D., Pomero, F., & Mastroiacovo, D. (2020) · Blood transfusion · doi:10.2450/2019.0265-18 · Cited by 12
Thromboinflammation as a Driver of Venous Thromboembolism
Gauchel, N., Krauel, K., Hamad, M. A., Bode, C., & Duerschmied, D. (2021) · Hämostaseologie · doi:10.1055/a-1661-0257 · Cited by 10
Milan, M., Noventa, F., Ghirarduzzi, A., Pengo, V., Vedovetto, V., FILIPPI, L., Campello, E., & Prandoni, P. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04865.x · Cited by 10
Self-citationAtherosclerosis and venous thromboembolism — similarities
Undas, A. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0322 · Cited by 10
Pellegrini, V. D. (2015) · JBJS Reviews · doi:10.2106/jbjs.rvw.n.00111 · Cited by 10
Metadata
- Authors
- Becattini, C., Agnelli, G., Schenone, A., Eichinger, S., Bucherini, E., Silingardi, M., Bianchi, M., Moia, M., Ageno, W., Vandelli, M. R., Grandone, E., & Prandoni, P.
- Affiliations
- University of Perugia (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Medical University of Vienna (AT)
- Ospedale per gli Infermi (IT)
- Santa Maria Nuova Hospital (IT)
- Ospedale Valduce (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Insubria (IT)
- Casa Sollievo della Sofferenza (IT)
- University of Padua (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-24
- Volume
- 366
- Issue
- 21
- Pages
- 1959-1967
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1975990989
- Cited by
- 620
- References
- 37
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 11 · 2022: 23 · 2021: 39 · 2020: 40 · 2019: 34 · 2018: 45 · 2017: 53 · 2016: 52 · 2015: 75 · 2014: 69 · 2013: 90 · 2012: 33
- FWCI
- 57.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Iris (University of Trento) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Bayer HealthCare
- Università degli Studi di Perugia
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, major bleeding, secondary prevention, anticoagulation
- MeSH terms
- Aged, Anticoagulants, Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Pulmonary Embolism, Vitamin K, Venous Thrombosis, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.